Sunshine Guojian Pharmaceutical's high P/S ratio may be due ...
Sunshine Guojian Pharmaceutical's high P/S ratio may be due to expectations of strong revenue performance. However, with less than stellar revenue forecasts, the P/S could fall if sentiment doesn't improve. Investors should remain cautious.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more